Cost-effectiveness of velpatasvir/sofosbuvir for the treatment of hepatitis C in Colombia

Colombia reported that 1.6% of all deaths between 1997-2020 may have been linked to Hepatitis C virus (HCV) infection. In order to inform decisions to improve HCV care, we developed a Markov model to estimate the cost-effectiveness of pan-genotypic DAA regimen (velpatasvir/sofosbuvir, SOF/VEL) for t...

Full description

Autores:

Paternina Caicedo, A.
Alvis Guzman, N.
Alvis Zakzuk, J.
De La Hoz, F.

Tipo de recurso:

Article of investigation

Fecha de publicación:

2023

Institución:

Corporación Universidad de la Costa

Repositorio:

REDICUC - Repositorio CUC

Idioma:

eng

OAI Identifier:

oai:repositorio.cuc.edu.co:11323/13704

Acceso en línea:

https://hdl.handle.net/11323/13704
https://repositorio.cuc.edu.co/

Palabra clave:

Hepatitis c
HCV
Velpatasvir/sofosbuvir
SOF/VEL

Rights

openAccess

License

Atribución 4.0 Internacional (CC BY 4.0)